Acellular pertussis vaccination facilitatesBordetella parapertussisinfection in a rodent model of bordetellosis
- 3 March 2010
- journal article
- research article
- Published by The Royal Society in Proceedings Of The Royal Society B-Biological Sciences
- Vol. 277 (1690) , 2017-2025
- https://doi.org/10.1098/rspb.2010.0010
Abstract
Despite over 50 years of population-wide vaccination, whooping cough incidence is on the rise. Although Bordetella pertussis is considered the main causative agent of whooping cough in humans, Bordetella parapertussis infections are not uncommon. The widely used acellular whooping cough vaccines (aP) are comprised solely of B. pertussis antigens that hold little or no efficacy against B. parapertussis. Here, we ask how aP vaccination affects competitive interactions between Bordetella species within co-infected rodent hosts and thus the aP-driven strength and direction of in-host selection. We show that aP vaccination helped clear B. pertussis but resulted in an approximately 40-fold increase in B. parapertussis lung colony-forming units (CFUs). Such vaccine-mediated facilitation of B. parapertussis did not arise as a result of competitive release; B. parapertussis CFUs were higher in aP-relative to sham-vaccinated hosts regardless of whether infections were single or mixed. Further, we show that aP vaccination impedes host immunity against B. parapertussis—measured as reduced lung inflammatory and neutrophil responses. Thus, we conclude that aP vaccination interferes with the optimal clearance of B. parapertussis and enhances the performance of this pathogen. Our data raise the possibility that widespread aP vaccination can create hosts more susceptible to B. parapertussis infection.Keywords
This publication has 48 references indexed in Scilit:
- The O Antigen Is a Critical Antigen for the Development of a Protective Immune Response to Bordetella parapertussisInfection and Immunity, 2009
- O Antigen Allows B. parapertussis to Evade B. pertussis Vaccine–Induced Immunity by Blocking Binding and Functions of Cross-Reactive AntibodiesPLOS ONE, 2009
- Inefficient Toll-Like Receptor-4 Stimulation Enables Bordetella parapertussis to Avoid Host ImmunityPLOS ONE, 2009
- O Antigen Protects Bordetella parapertussis from ComplementInfection and Immunity, 2008
- The O Antigen Enables Bordetella parapertussis To Avoid Bordetella pertussis -Induced ImmunityInfection and Immunity, 2007
- Live Attenuated B. pertussis as a Single-Dose Nasal Vaccine against Whooping CoughPLoS Pathogens, 2006
- Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due toBordetella pertussisand OtherBordetellaSubspeciesClinical Microbiology Reviews, 2005
- Adaptation of Bordetella pertussis to Vaccination: A Cause for Its Reemergence?Emerging Infectious Diseases, 2001
- Modelling a Predictable Disaster:Parasitology Today, 2000
- Mixed outbreak ofBordetella pertussis andBordetella parapertussis infection in FinlandEuropean Journal of Clinical Microbiology & Infectious Diseases, 1985